chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Lymphadenopathy, Pharyngeal swelling
Clinical narrative: Lymphnodes swollen under right arm; throat swollen; trouble breathing especially at night; This is a spontaneous report received from a contactable consumer (Patient). A 51-year-old non-pregnant female patient received bnt162b2 (BNT162B2; Solution for injection; Lot number: Unknown), via an unspecified route of administration, administered in right arm as dose number unknown, single on 27Apr2021 at 09:00 (at the age of 51-year-old) for covid-19 immunisation at doctor's office/urgent care. Patient had no known allergies and had been diagnosed with COVID-19 prior to vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Patient had not been tested for Covid 19 since the vaccination. The patient's concomitant medications were not reported. On 28Apr2021 at 21:00, the patient experienced lymph nodes swollen under right arm, throat swollen and trouble breathing especially at night. No treatment was received as result of adverse events. Device Date was 01May2021. At the time of this report, the outcome of events was not recovered.  No follow up attempts are needed. Information about lot/batch number cannot be obtained.
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Blister, Body temperature, Bone disorder, Chills, Decreased appetite
Clinical narrative: muscle pain; Today, very short of breath; temp 102.5; uncontrollable chills; no appetite; no thirst; blistering; headache; weird bone; This is a spontaneous report from a contactable consumer reported for male (patient himself). A 53-years-old male patient received (BNT162B2, PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: Solution for injection, Lot Number: ER8729), via an unspecified route, administered in Left Arm on 28Apr2021 at 04:45 PM (53-years-old at vaccination) as Dose 2, Single for Covid-19 immunization. Facility of the most recent COVID-19 vaccine was administered was reported as Other. The patient's medical history included asthma, hypertension, high T3 (triiodothyronine). The patient's concomitant medications included levothyroxine sodium (SYNTHROID), liothyronine sodium (CYTOMEL) and nebivolol hydrochloride (BYSTOLIC) within 2 weeks of vaccination. The patient past medications included terramycin, tetracycline and penicillin and the patient was allergic to all past drugs. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously took historical vaccine BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: Solution for injection, Lot Number: EW0176), via an unspecified route, administered in Left Arm on 06Apr2021 at 03 :45 PM (53-year-old at vaccination) as Dose 1, Single for Covid-19 immunization. The patient had experienced BRVO (Branch Retinal Vein Occlusion) in the right eye approximately 1 week after first dose of injection. The patient received Shot in eyeball for 1st, nothing yet for the 2nd. On 28Apr2021 at 08:00 AM, the patient experienced muscle pain, very short of breath, temp 102.5, uncontrollable chills, no appetite, no thirst, blistering, headache, weird bone. Since the vaccination the patient had not been tested for COVID-19. These events resulted in doctor or other healthcare professional office/clinic visit. Patient received treatment medication for resulted events. Device date was reported as 28Apr2021. The clinical outcome of the events was unknown.  No follow-up attempts are needed. No further information was expected.
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea, Headache, Myalgia, Pyrexia, Thirst decreased
Clinical narrative: muscle pain; Today, very short of breath; temp 102.5; uncontrollable chills; no appetite; no thirst; blistering; headache; weird bone; This is a spontaneous report from a contactable consumer reported for male (patient himself). A 53-years-old male patient received (BNT162B2, PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: Solution for injection, Lot Number: ER8729), via an unspecified route, administered in Left Arm on 28Apr2021 at 04:45 PM (53-years-old at vaccination) as Dose 2, Single for Covid-19 immunization. Facility of the most recent COVID-19 vaccine was administered was reported as Other. The patient's medical history included asthma, hypertension, high T3 (triiodothyronine). The patient's concomitant medications included levothyroxine sodium (SYNTHROID), liothyronine sodium (CYTOMEL) and nebivolol hydrochloride (BYSTOLIC) within 2 weeks of vaccination. The patient past medications included terramycin, tetracycline and penicillin and the patient was allergic to all past drugs. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously took historical vaccine BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: Solution for injection, Lot Number: EW0176), via an unspecified route, administered in Left Arm on 06Apr2021 at 03 :45 PM (53-year-old at vaccination) as Dose 1, Single for Covid-19 immunization. The patient had experienced BRVO (Branch Retinal Vein Occlusion) in the right eye approximately 1 week after first dose of injection. The patient received Shot in eyeball for 1st, nothing yet for the 2nd. On 28Apr2021 at 08:00 AM, the patient experienced muscle pain, very short of breath, temp 102.5, uncontrollable chills, no appetite, no thirst, blistering, headache, weird bone. Since the vaccination the patient had not been tested for COVID-19. These events resulted in doctor or other healthcare professional office/clinic visit. Patient received treatment medication for resulted events. Device date was reported as 28Apr2021. The clinical outcome of the events was unknown.  No follow-up attempts are needed. No further information was expected.
Sex: U
Vaccine: COVID19
Symptoms: Chills, Nausea, Pain in extremity, Pyrexia
Clinical narrative: Sore arm; Chills; Fever; Nausea; This is a spontaneous report from a contactable consumer or other non hcp. A patient of unspecified age and gender received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number and expiration date were not reported) via an unspecified route of administration in arm on an unspecified date as dose 1, single for covid-19 immunization. The patient's medical history and concomitant medications were not reported. On an unspecified date, patient experienced sore arm, chills, fever, nausea. The outcome of all events was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Sex: U
Vaccine: COVID19
Symptoms: Dry throat, Dysphagia, Dysphonia, Hypersensitivity, Oral pruritus
Clinical narrative: I had an allergic reaction; My tongue starts very heavy; Roof of my mouth and I guess back of my mouth close to my throat  were itchy; progressed to feeling  like I have sand under my tongue; My throat was extremely dry; I had difficulty in swallowing the water; My voice was very raspy; This is a spontaneous report from a contactable consumer or other non healthcare professional (patient). A patient of unspecified age and gender received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration on 02Apr2021 (Batch/Lot Number: ER 3734, Expiry Date and NDC number were unknown),  as dose 1, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported.  On 02Apr2021, the patient reported that had couple of different side effect within 8 minutes of taking the shot had an allergic reaction, tongue starts very heavy, roof of mouth and guess back of mouth close to throat were itchy, progressed to feeling like having sand under tongue, throat was extremely dry, had difficulty in swallowing the water and voice was very raspy. The patient stated that they gave Benadryl, 2 doses.  LOT#: consumer stated, ER is that 3734, its 3 or 8, can't read it, let me see if can get something like a power glass if can make it little, larger, if can be more sure, it looks like it could be Pfizer ER looks like it might be could be a 3 could be a 8 can't really tell 734. The patient reported that, has a couple of quick question about Pfizer Vaccine, had the first vaccination, and had an allergic reaction. So, the CDC is saying that they don't recommend a second dose if you had reaction to first dose and want to know whether there is any allergist that could test me to see what it was that was allergic to shot. do you have list of those?  So, patient was referred, called the number and they referred patient to you regarding a negative response that had to the first Pfizer Vaccine, and have seen on the CDC website that if you have negative or allergic reaction to the first vaccine then the second vaccine should not be taken. The patient actually has two questions. Does Pfizer have a list of providers or allergic that could test to see what people are allergic to in their shot? So, you have any information so that patient could contact or get an appointment to the allergist in my state? The next question is if patient not able to take the second dose, would be able to check the MODERNA dose because it is also an MRNA shot. The outcome of the events was unknown.  Product details (LOT, Expiration Date, NDC and UPC) and Pharmacy details could not be probed as consumer hung up the call abruptly. Hence further probing could not be done. Consent to follow up with the patient which stated, so that why they need my email address so that can follow up with me, that makes sense. ok that's fine, well they can follow up with me by phone.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Sex: U
Vaccine: COVID19
Symptoms: Tongue discomfort, Tongue disorder
Clinical narrative: I had an allergic reaction; My tongue starts very heavy; Roof of my mouth and I guess back of my mouth close to my throat  were itchy; progressed to feeling  like I have sand under my tongue; My throat was extremely dry; I had difficulty in swallowing the water; My voice was very raspy; This is a spontaneous report from a contactable consumer or other non healthcare professional (patient). A patient of unspecified age and gender received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration on 02Apr2021 (Batch/Lot Number: ER 3734, Expiry Date and NDC number were unknown),  as dose 1, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported.  On 02Apr2021, the patient reported that had couple of different side effect within 8 minutes of taking the shot had an allergic reaction, tongue starts very heavy, roof of mouth and guess back of mouth close to throat were itchy, progressed to feeling like having sand under tongue, throat was extremely dry, had difficulty in swallowing the water and voice was very raspy. The patient stated that they gave Benadryl, 2 doses.  LOT#: consumer stated, ER is that 3734, its 3 or 8, can't read it, let me see if can get something like a power glass if can make it little, larger, if can be more sure, it looks like it could be Pfizer ER looks like it might be could be a 3 could be a 8 can't really tell 734. The patient reported that, has a couple of quick question about Pfizer Vaccine, had the first vaccination, and had an allergic reaction. So, the CDC is saying that they don't recommend a second dose if you had reaction to first dose and want to know whether there is any allergist that could test me to see what it was that was allergic to shot. do you have list of those?  So, patient was referred, called the number and they referred patient to you regarding a negative response that had to the first Pfizer Vaccine, and have seen on the CDC website that if you have negative or allergic reaction to the first vaccine then the second vaccine should not be taken. The patient actually has two questions. Does Pfizer have a list of providers or allergic that could test to see what people are allergic to in their shot? So, you have any information so that patient could contact or get an appointment to the allergist in my state? The next question is if patient not able to take the second dose, would be able to check the MODERNA dose because it is also an MRNA shot. The outcome of the events was unknown.  Product details (LOT, Expiration Date, NDC and UPC) and Pharmacy details could not be probed as consumer hung up the call abruptly. Hence further probing could not be done. Consent to follow up with the patient which stated, so that why they need my email address so that can follow up with me, that makes sense. ok that's fine, well they can follow up with me by phone.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Axillary pain, Body temperature, Breast pain, Dizziness
Clinical narrative: Headache; Nausea; Light headedness; Fatigue; Metal taste; Swelling and numbness whole arm/hand; Swelling and numbness whole arm/hand; Pain x4 days; Lung inhale feels abnormal; Face hot/flushed; Low grade fever; Deep pain in armpit, elbow, hand and breast area; Deep pain in armpit, elbow, hand and breast area; Deep pain in armpit, elbow, hand and breast area; Deep pain in armpit, elbow, hand and breast area; This is a spontaneous report from a contactable consumer (patient). A 49-years-old non pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot Number: EL9266) dose 1 via an unspecified route of administration, administered in Arm Left on 03Apr2021 15:00 as DOSE 1, SINGLE, dose 2 via an unspecified route of administration on 24Apr2021 (Batch/Lot number was not reported) (at the age of 49-years-old) as DOSE 2, SINGLE for covid-19 immunization at pharmacy or drug store. The patient was not pregnant at time of vaccination. Patient medical history included chronic bronchitis (not currently active though) from an unknown date and unknown if ongoing. Patient concomitant medication(s) included rosuvastatin (ROSUVASTATIN) 10 mg, ergocalciferol (VIT D), cyanocobalamin (VITAMIN B12 [CYANOCOBALAMIN]), Multivit and ubidecarenone (COQ 10), all were taken for an unspecified indication, start and stop date were not reported for any. The patient had no known allergies. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 03Apr2021 16:30, the patient experienced headache, nausea, light headedness, fatigue, metal taste, swelling and numbness in whole arm/hand, pain x4 days, lung inhale feels abnormal, face hot/flushed, had low grade fever and had deep pain in armpit, elbow, hand and breast area. On 03Apr2021, the patient underwent lab tests and procedures which included body temperature which was found to be low grade. The patient did not received any treatment for the events. The outcome of events was not recovered.    No follow-up attempts are needed. No further information is expected.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Dysgeusia, Fatigue, Flushing, Headache, Hypoaesthesia
Clinical narrative: Headache; Nausea; Light headedness; Fatigue; Metal taste; Swelling and numbness whole arm/hand; Swelling and numbness whole arm/hand; Pain x4 days; Lung inhale feels abnormal; Face hot/flushed; Low grade fever; Deep pain in armpit, elbow, hand and breast area; Deep pain in armpit, elbow, hand and breast area; Deep pain in armpit, elbow, hand and breast area; Deep pain in armpit, elbow, hand and breast area; This is a spontaneous report from a contactable consumer (patient). A 49-years-old non pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot Number: EL9266) dose 1 via an unspecified route of administration, administered in Arm Left on 03Apr2021 15:00 as DOSE 1, SINGLE, dose 2 via an unspecified route of administration on 24Apr2021 (Batch/Lot number was not reported) (at the age of 49-years-old) as DOSE 2, SINGLE for covid-19 immunization at pharmacy or drug store. The patient was not pregnant at time of vaccination. Patient medical history included chronic bronchitis (not currently active though) from an unknown date and unknown if ongoing. Patient concomitant medication(s) included rosuvastatin (ROSUVASTATIN) 10 mg, ergocalciferol (VIT D), cyanocobalamin (VITAMIN B12 [CYANOCOBALAMIN]), Multivit and ubidecarenone (COQ 10), all were taken for an unspecified indication, start and stop date were not reported for any. The patient had no known allergies. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 03Apr2021 16:30, the patient experienced headache, nausea, light headedness, fatigue, metal taste, swelling and numbness in whole arm/hand, pain x4 days, lung inhale feels abnormal, face hot/flushed, had low grade fever and had deep pain in armpit, elbow, hand and breast area. On 03Apr2021, the patient underwent lab tests and procedures which included body temperature which was found to be low grade. The patient did not received any treatment for the events. The outcome of events was not recovered.    No follow-up attempts are needed. No further information is expected.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pain, Pain in extremity, Peripheral swelling, Pyrexia
Clinical narrative: Headache; Nausea; Light headedness; Fatigue; Metal taste; Swelling and numbness whole arm/hand; Swelling and numbness whole arm/hand; Pain x4 days; Lung inhale feels abnormal; Face hot/flushed; Low grade fever; Deep pain in armpit, elbow, hand and breast area; Deep pain in armpit, elbow, hand and breast area; Deep pain in armpit, elbow, hand and breast area; Deep pain in armpit, elbow, hand and breast area; This is a spontaneous report from a contactable consumer (patient). A 49-years-old non pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot Number: EL9266) dose 1 via an unspecified route of administration, administered in Arm Left on 03Apr2021 15:00 as DOSE 1, SINGLE, dose 2 via an unspecified route of administration on 24Apr2021 (Batch/Lot number was not reported) (at the age of 49-years-old) as DOSE 2, SINGLE for covid-19 immunization at pharmacy or drug store. The patient was not pregnant at time of vaccination. Patient medical history included chronic bronchitis (not currently active though) from an unknown date and unknown if ongoing. Patient concomitant medication(s) included rosuvastatin (ROSUVASTATIN) 10 mg, ergocalciferol (VIT D), cyanocobalamin (VITAMIN B12 [CYANOCOBALAMIN]), Multivit and ubidecarenone (COQ 10), all were taken for an unspecified indication, start and stop date were not reported for any. The patient had no known allergies. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 03Apr2021 16:30, the patient experienced headache, nausea, light headedness, fatigue, metal taste, swelling and numbness in whole arm/hand, pain x4 days, lung inhale feels abnormal, face hot/flushed, had low grade fever and had deep pain in armpit, elbow, hand and breast area. On 03Apr2021, the patient underwent lab tests and procedures which included body temperature which was found to be low grade. The patient did not received any treatment for the events. The outcome of events was not recovered.    No follow-up attempts are needed. No further information is expected.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Respiration abnormal
Clinical narrative: Headache; Nausea; Light headedness; Fatigue; Metal taste; Swelling and numbness whole arm/hand; Swelling and numbness whole arm/hand; Pain x4 days; Lung inhale feels abnormal; Face hot/flushed; Low grade fever; Deep pain in armpit, elbow, hand and breast area; Deep pain in armpit, elbow, hand and breast area; Deep pain in armpit, elbow, hand and breast area; Deep pain in armpit, elbow, hand and breast area; This is a spontaneous report from a contactable consumer (patient). A 49-years-old non pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot Number: EL9266) dose 1 via an unspecified route of administration, administered in Arm Left on 03Apr2021 15:00 as DOSE 1, SINGLE, dose 2 via an unspecified route of administration on 24Apr2021 (Batch/Lot number was not reported) (at the age of 49-years-old) as DOSE 2, SINGLE for covid-19 immunization at pharmacy or drug store. The patient was not pregnant at time of vaccination. Patient medical history included chronic bronchitis (not currently active though) from an unknown date and unknown if ongoing. Patient concomitant medication(s) included rosuvastatin (ROSUVASTATIN) 10 mg, ergocalciferol (VIT D), cyanocobalamin (VITAMIN B12 [CYANOCOBALAMIN]), Multivit and ubidecarenone (COQ 10), all were taken for an unspecified indication, start and stop date were not reported for any. The patient had no known allergies. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 03Apr2021 16:30, the patient experienced headache, nausea, light headedness, fatigue, metal taste, swelling and numbness in whole arm/hand, pain x4 days, lung inhale feels abnormal, face hot/flushed, had low grade fever and had deep pain in armpit, elbow, hand and breast area. On 03Apr2021, the patient underwent lab tests and procedures which included body temperature which was found to be low grade. The patient did not received any treatment for the events. The outcome of events was not recovered.    No follow-up attempts are needed. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia
Clinical narrative: Joint pain two weeks after second dose; This is a spontaneous report from a contactable consumer (Patient reported for herself).  A 63-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; solution for injection, Lot Number: EW0151), via unspecified route of administration, in right arm on 10Apr2021 13:00 as a dose 2, single for COVID-19 immunization. The patient medical history included lichen planus. The concomitant medication of the patient was not reported. Patient previously received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number: ER2613), via unspecified route of administration, in left arm on 20Mar2021 01:00 PM as a dose 1, single for COVID-19 immunization. Patient not receive any other vaccines within 4 weeks prior to the COVID vaccine. Patient not received any other medications within 2 weeks of vaccination. Prior to vaccination, patient was not diagnosed and since the vaccination, the patient was not tested for COVID-19. On 22Apr2021 13:00 the patient experienced joint pain two weeks after second dose. Outcome of the reported event was recovered on an unspecified date of 2021.  No follow-up attempts are needed. No further information is expected.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Bedridden, Bone pain, Chills, Headache, Pyrexia
Clinical narrative: Headache, vomiting, dry heaves, chills, fever, achey bones that kept patient bedridden for 48 hours. Unable to keep liquids or food in stomach for 24 hours. Excruciating headache from cervical spine t; Headache, vomiting, dry heaves, chills, fever, achey bones that kept patient bedridden for 48 hours. Unable to keep liquids or food in stomach for 24 hours. Excruciating headache from cervical spine t; Headache, vomiting, dry heaves, chills, fever, achey bones that kept patient bedridden for 48 hours. Unable to keep liquids or food in stomach for 24 hours. Excruciating headache from cervical spine t; Headache, vomiting, dry heaves, chills, fever, achey bones that kept patient bedridden for 48 hours. Unable to keep liquids or food in stomach for 24 hours. Excruciating headache from cervical spine t; Headache, vomiting, dry heaves, chills, fever, achey bones that kept patient bedridden for 48 hours. Unable to keep liquids or food in stomach for 24 hours. Excruciating headache from cervical spine t; Headache, vomiting, dry heaves, chills, fever, achey bones that kept patient bedridden for 48 hours. Unable to keep liquids or food in stomach for 24 hours. Excruciating headache from cervical spine t; Headache, vomiting, dry heaves, chills, fever, achey bones that kept patient bedridden for 48 hours. Unable to keep liquids or food in stomach for 24 hours. Excruciating headache from cervical spine t; This is a spontaneous report from a non-contactable consumer or other non health care professional. This consumer (patient) reported that a 62-years-old non-pregnant female patient received bnt162b2(PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: EW0161), via an unspecified route of administration, administered in Arm Right on 22Apr2021 at 11:00(at the age of 62-years) as dose 2, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The historical vaccines include bnt162b2(PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: EP 7533), via an unspecified route of administration, administered in Arm Right on 01Apr2021 at 01:00 PM as dose 1, single for COVID-19 immunisation. On 22Apr2021 23:30, the patient experienced headache, vomiting, dry heaves, chills, fever, achey bones that kept patient bedridden for 48 hours. The patient was unable to keep liquids or food in stomach for 24 hours. Excruciating headache from cervical spine to head. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not receive any other medications received within 2 weeks of vaccination. The patient was not diagnosed with COVID-19. The patient has not been tested for COVID-19 since vaccination. The clinical outcome of event was recovered on an unspecified date in 2021.  No follow-up attempts are possible. Information about lot/batch number cannot be obtained.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Retching, Vomiting
Clinical narrative: Headache, vomiting, dry heaves, chills, fever, achey bones that kept patient bedridden for 48 hours. Unable to keep liquids or food in stomach for 24 hours. Excruciating headache from cervical spine t; Headache, vomiting, dry heaves, chills, fever, achey bones that kept patient bedridden for 48 hours. Unable to keep liquids or food in stomach for 24 hours. Excruciating headache from cervical spine t; Headache, vomiting, dry heaves, chills, fever, achey bones that kept patient bedridden for 48 hours. Unable to keep liquids or food in stomach for 24 hours. Excruciating headache from cervical spine t; Headache, vomiting, dry heaves, chills, fever, achey bones that kept patient bedridden for 48 hours. Unable to keep liquids or food in stomach for 24 hours. Excruciating headache from cervical spine t; Headache, vomiting, dry heaves, chills, fever, achey bones that kept patient bedridden for 48 hours. Unable to keep liquids or food in stomach for 24 hours. Excruciating headache from cervical spine t; Headache, vomiting, dry heaves, chills, fever, achey bones that kept patient bedridden for 48 hours. Unable to keep liquids or food in stomach for 24 hours. Excruciating headache from cervical spine t; Headache, vomiting, dry heaves, chills, fever, achey bones that kept patient bedridden for 48 hours. Unable to keep liquids or food in stomach for 24 hours. Excruciating headache from cervical spine t; This is a spontaneous report from a non-contactable consumer or other non health care professional. This consumer (patient) reported that a 62-years-old non-pregnant female patient received bnt162b2(PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: EW0161), via an unspecified route of administration, administered in Arm Right on 22Apr2021 at 11:00(at the age of 62-years) as dose 2, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The historical vaccines include bnt162b2(PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: EP 7533), via an unspecified route of administration, administered in Arm Right on 01Apr2021 at 01:00 PM as dose 1, single for COVID-19 immunisation. On 22Apr2021 23:30, the patient experienced headache, vomiting, dry heaves, chills, fever, achey bones that kept patient bedridden for 48 hours. The patient was unable to keep liquids or food in stomach for 24 hours. Excruciating headache from cervical spine to head. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not receive any other medications received within 2 weeks of vaccination. The patient was not diagnosed with COVID-19. The patient has not been tested for COVID-19 since vaccination. The clinical outcome of event was recovered on an unspecified date in 2021.  No follow-up attempts are possible. Information about lot/batch number cannot be obtained.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Dizziness, Head discomfort, Headache
Clinical narrative: The next day, had chills and fever, muscle and joint pain. Next day, I woke up and felt pain on left side of my neck and could not turn my head towards; The next day, had chills and fever, muscle and joint pain.; The next day, had chills and fever, muscle and joint pain.; The next day, had chills and fever, muscle and joint pain.; 2 hrs after 2nd dose, I was dizzy and nauseous.; 2 hrs after 2nd dose, I was dizzy and nauseous.; Noticeable swelling in the area between left neck and shoulder towards left half of nape/ swelling on back of nape feels like a pinched nerve; felt pain on left side of my neck; Two lymph nodes swollen and painful to touch; could not turn my head towards the left; feels like a pinched nerve giving me headache; This is a spontaneous report from a contactable consumer (patient). A 53 years old non-pregnant female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot number and Expiry date was not reported), via an unspecified route, administrated in left arm on 23Apr2021 at 15:15 (at age of 53-years-old) as Dose 2, Single for Covid-19 immunization in Pharmacy or Drug Store. The patient was non-pregnant at time of vaccination. The patient's medical history included ongoing migraine, kidney stones, known allergies to Avocado, Almonds and Walnuts. The patient's concomitant medication(s) included propranolol; omeprazole; erenumab aooe (AIMOVIG); frovatriptan within 2 weeks of vaccination. The patient's past drug included clindamycin and experienced drug allergy. The patient had not received any other vaccine within 4 weeks. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient previously received first dose of bnt162b2 (COMIRNATY, Formulation: Solution for injection, Batch/Lot number: EN6207, Expiration Date: Not reported), via an unspecified route of administration in left arm on 02Apr2021 at 15:45 (at age of 53-years-old) as Dose 1, Single for Covid-19 immunization. On 23Apr2021 at 17:30 (approximately 2 hrs after second dose of vaccination), the patient was dizzy and nauseous. On 24Apr2021 (the next day), the patient had experienced had chills and fever, muscle and joint pain. (Next day on unspecified date in Apr2021), she woke up and felt pain on left side of her neck and could not turn her head towards the left. On an unspecified date in Apr2021, the patient experienced noticeable swelling in the area between left neck and shoulder towards left half of nape, two lymph nodes swollen and painful to touch, swelling on back of nape feels like a pinched nerve giving her headache. Since the vaccination, the patient was not tested for COVID-19. No treatment received for resulted events. Device date was reported as 26Ap2021. The outcome of the events was not recovered.   No Follow-up attempts are needed. No further information was expected.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy, Myalgia, Nausea, Neck pain, Pyrexia
Clinical narrative: The next day, had chills and fever, muscle and joint pain. Next day, I woke up and felt pain on left side of my neck and could not turn my head towards; The next day, had chills and fever, muscle and joint pain.; The next day, had chills and fever, muscle and joint pain.; The next day, had chills and fever, muscle and joint pain.; 2 hrs after 2nd dose, I was dizzy and nauseous.; 2 hrs after 2nd dose, I was dizzy and nauseous.; Noticeable swelling in the area between left neck and shoulder towards left half of nape/ swelling on back of nape feels like a pinched nerve; felt pain on left side of my neck; Two lymph nodes swollen and painful to touch; could not turn my head towards the left; feels like a pinched nerve giving me headache; This is a spontaneous report from a contactable consumer (patient). A 53 years old non-pregnant female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot number and Expiry date was not reported), via an unspecified route, administrated in left arm on 23Apr2021 at 15:15 (at age of 53-years-old) as Dose 2, Single for Covid-19 immunization in Pharmacy or Drug Store. The patient was non-pregnant at time of vaccination. The patient's medical history included ongoing migraine, kidney stones, known allergies to Avocado, Almonds and Walnuts. The patient's concomitant medication(s) included propranolol; omeprazole; erenumab aooe (AIMOVIG); frovatriptan within 2 weeks of vaccination. The patient's past drug included clindamycin and experienced drug allergy. The patient had not received any other vaccine within 4 weeks. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient previously received first dose of bnt162b2 (COMIRNATY, Formulation: Solution for injection, Batch/Lot number: EN6207, Expiration Date: Not reported), via an unspecified route of administration in left arm on 02Apr2021 at 15:45 (at age of 53-years-old) as Dose 1, Single for Covid-19 immunization. On 23Apr2021 at 17:30 (approximately 2 hrs after second dose of vaccination), the patient was dizzy and nauseous. On 24Apr2021 (the next day), the patient had experienced had chills and fever, muscle and joint pain. (Next day on unspecified date in Apr2021), she woke up and felt pain on left side of her neck and could not turn her head towards the left. On an unspecified date in Apr2021, the patient experienced noticeable swelling in the area between left neck and shoulder towards left half of nape, two lymph nodes swollen and painful to touch, swelling on back of nape feels like a pinched nerve giving her headache. Since the vaccination, the patient was not tested for COVID-19. No treatment received for resulted events. Device date was reported as 26Ap2021. The outcome of the events was not recovered.   No Follow-up attempts are needed. No further information was expected.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Swelling
Clinical narrative: The next day, had chills and fever, muscle and joint pain. Next day, I woke up and felt pain on left side of my neck and could not turn my head towards; The next day, had chills and fever, muscle and joint pain.; The next day, had chills and fever, muscle and joint pain.; The next day, had chills and fever, muscle and joint pain.; 2 hrs after 2nd dose, I was dizzy and nauseous.; 2 hrs after 2nd dose, I was dizzy and nauseous.; Noticeable swelling in the area between left neck and shoulder towards left half of nape/ swelling on back of nape feels like a pinched nerve; felt pain on left side of my neck; Two lymph nodes swollen and painful to touch; could not turn my head towards the left; feels like a pinched nerve giving me headache; This is a spontaneous report from a contactable consumer (patient). A 53 years old non-pregnant female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot number and Expiry date was not reported), via an unspecified route, administrated in left arm on 23Apr2021 at 15:15 (at age of 53-years-old) as Dose 2, Single for Covid-19 immunization in Pharmacy or Drug Store. The patient was non-pregnant at time of vaccination. The patient's medical history included ongoing migraine, kidney stones, known allergies to Avocado, Almonds and Walnuts. The patient's concomitant medication(s) included propranolol; omeprazole; erenumab aooe (AIMOVIG); frovatriptan within 2 weeks of vaccination. The patient's past drug included clindamycin and experienced drug allergy. The patient had not received any other vaccine within 4 weeks. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient previously received first dose of bnt162b2 (COMIRNATY, Formulation: Solution for injection, Batch/Lot number: EN6207, Expiration Date: Not reported), via an unspecified route of administration in left arm on 02Apr2021 at 15:45 (at age of 53-years-old) as Dose 1, Single for Covid-19 immunization. On 23Apr2021 at 17:30 (approximately 2 hrs after second dose of vaccination), the patient was dizzy and nauseous. On 24Apr2021 (the next day), the patient had experienced had chills and fever, muscle and joint pain. (Next day on unspecified date in Apr2021), she woke up and felt pain on left side of her neck and could not turn her head towards the left. On an unspecified date in Apr2021, the patient experienced noticeable swelling in the area between left neck and shoulder towards left half of nape, two lymph nodes swollen and painful to touch, swelling on back of nape feels like a pinched nerve giving her headache. Since the vaccination, the patient was not tested for COVID-19. No treatment received for resulted events. Device date was reported as 26Ap2021. The outcome of the events was not recovered.   No Follow-up attempts are needed. No further information was expected.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia, Paraesthesia oral, Swelling face
Clinical narrative: Midline facial tingling/number starting 30 min after administration. Tingling extends to tongue.; Midline facial tingling/number starting 30 min after administration. Tingling extends to tongue.; On exam pt is neuro intact but has mild right sided facial swelling; This is a spontaneous report received from a contactable physician. The physician reported for a female patient.  A 43-year-old female patient received second dose of BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot Number- EW0172) intramuscularly, in left arm on 01May2021 at 20:00 as dose 2, single (at the age of 43-years-old) for COVID-19 immunization. The patient medical history included hypercholesterolemia, Covid-19. The concomitant medication of the patient included phentermine (PHENTERMINE). The patient previously received BNT162B2 (PFIZER BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0162) via intramuscularly, in left arm on 10Apr2021 as a dose 1, single for COVID-19 immunization. On an unspecified date prior to vaccination, the patient was diagnosed with COVID-19. Patient had no known allergies. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Since the vaccination, the patient was not tested for COVID-19. On 01May2021 at 20:30 the patient experienced midline facial tingling/number starting 30 minutes after administration. Tingling extends to tongue. On examination patient was neuro intact but had mild right sided facial swelling. Patient had emergency room visit for the reported events. Patient received the treatment of prednisone 60 mg, diphenhydramine 25 mg and famotidine 40 mg for the reported events. Outcome of all the reported events was unknown.  No follow-up attempts are needed. No further information is expected.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Hot flush, Night sweats, Pain in extremity
Clinical narrative: Experienced heavy pain in opposite arm of injection; Hot flashes; Chills; Joint pain; Rash; Night sweats; This is a spontaneous report from a contactable consumer. A 32years female (nonpregnant) patient received bnt162b2 (BNT162B2, Formulation: Solution for injection, Batch/Lot Number: ER8737) was administered on 06Apr2021 at 12:00pm (age at vaccination was 32) as dose 1, single for covid 19 immunization. The patient medical history and concurrent conditions was Depression, migraine. Patient did not take any other vaccine in four weeks. No covid prior vaccination and did not tested covid post vaccination. On 07Apr2021 11:00 patient Experienced heavy pain in opposite arm of injection, hot flashes, chills, joint pain, rash and night sweats. All occurred 1-11 days after injection. The patient didn't received any treatment. The outcome of all events was Recovered on an unknown date on 2021.  No follow-up attempts are needed. No further information is expected.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Experienced heavy pain in opposite arm of injection; Hot flashes; Chills; Joint pain; Rash; Night sweats; This is a spontaneous report from a contactable consumer. A 32years female (nonpregnant) patient received bnt162b2 (BNT162B2, Formulation: Solution for injection, Batch/Lot Number: ER8737) was administered on 06Apr2021 at 12:00pm (age at vaccination was 32) as dose 1, single for covid 19 immunization. The patient medical history and concurrent conditions was Depression, migraine. Patient did not take any other vaccine in four weeks. No covid prior vaccination and did not tested covid post vaccination. On 07Apr2021 11:00 patient Experienced heavy pain in opposite arm of injection, hot flashes, chills, joint pain, rash and night sweats. All occurred 1-11 days after injection. The patient didn't received any treatment. The outcome of all events was Recovered on an unknown date on 2021.  No follow-up attempts are needed. No further information is expected.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Hyperaesthesia, Muscle discomfort, Musculoskeletal pain, Neck pain
Clinical narrative: Extreme hip/joint pain in left leg (glute Med area extremely sensitive to touch) Extreme Pain experienced with sitting on the left hip/side and also when attempting to stand.; Walking around slowly seemed to warm up the muscle with less discomfort; Any rotation at the hip brought on sharp pain as well though (around that glute med,TFL area, around hip); Pain also radiated down to toes; some neck pain; Extreme hip/joint pain in left leg (glute Med area extremely sensitive to touch) Extreme Pain experienced with sitting on the left hip/side and also when attempting to stand.; injection site pain; This is a spontaneous report from a contactable consumer (patient herself). A 44-years-old non-pregnant female patient received bnt162b2 (BNT162B2, formulation: solution for injection, lot number: EW0153, expiration date: not reported), intramuscular, administered in Arm Right on 30Apr2021 12:30 (age at vaccination 44-year-old) as dose 2, single for covid-19 immunization at Pharmacy or Drug Store. Medical history included Iliosoas (hip) injury from 2013 to an unknown date, Exercise induced bronco-spasms from an unknown date and unknown if ongoing, Pre-Diabetic from an unknown date and unknown if ongoing. Patient previously took Pfizer COVID-19 vaccine on 09Apr2021 12:15 PM (lot number: EW0170) administered via Intramuscular route in Right arm (age at vaccination 44-year-old) as dose 1 single for COVID-19 immunization. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not receive within 2 weeks of vaccination. Since the vaccination the patient had been tested for covid-19. Prior to vaccination the patient was not diagnosed with Covid-19. The patients concomitant medications were not reported. On 02May2021 at 12:30, the patient experienced extreme hip/joint pain in left leg (glute med area extremely sensitive to touch) extreme pain experienced with sitting on the left hip/side and also when attempting to stand, walking around slowly seemed to warm up the muscle with less discomfort, any rotation at the hip brought on sharp pain as well though (around that glute med, tfl area, around hip), pain also radiated down to toes, injection site pain, some neck pain. Patient was self-treated with ice packs, compression, elevation & Biofreeze (topical menthol pain reliever) PRN as a therapeutic measure for all the events. The clinical outcome of the events was reported as recovering.  No follow-up attempts are needed. No further information is expected.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Vaccination site pain
Clinical narrative: Extreme hip/joint pain in left leg (glute Med area extremely sensitive to touch) Extreme Pain experienced with sitting on the left hip/side and also when attempting to stand.; Walking around slowly seemed to warm up the muscle with less discomfort; Any rotation at the hip brought on sharp pain as well though (around that glute med,TFL area, around hip); Pain also radiated down to toes; some neck pain; Extreme hip/joint pain in left leg (glute Med area extremely sensitive to touch) Extreme Pain experienced with sitting on the left hip/side and also when attempting to stand.; injection site pain; This is a spontaneous report from a contactable consumer (patient herself). A 44-years-old non-pregnant female patient received bnt162b2 (BNT162B2, formulation: solution for injection, lot number: EW0153, expiration date: not reported), intramuscular, administered in Arm Right on 30Apr2021 12:30 (age at vaccination 44-year-old) as dose 2, single for covid-19 immunization at Pharmacy or Drug Store. Medical history included Iliosoas (hip) injury from 2013 to an unknown date, Exercise induced bronco-spasms from an unknown date and unknown if ongoing, Pre-Diabetic from an unknown date and unknown if ongoing. Patient previously took Pfizer COVID-19 vaccine on 09Apr2021 12:15 PM (lot number: EW0170) administered via Intramuscular route in Right arm (age at vaccination 44-year-old) as dose 1 single for COVID-19 immunization. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not receive within 2 weeks of vaccination. Since the vaccination the patient had been tested for covid-19. Prior to vaccination the patient was not diagnosed with Covid-19. The patients concomitant medications were not reported. On 02May2021 at 12:30, the patient experienced extreme hip/joint pain in left leg (glute med area extremely sensitive to touch) extreme pain experienced with sitting on the left hip/side and also when attempting to stand, walking around slowly seemed to warm up the muscle with less discomfort, any rotation at the hip brought on sharp pain as well though (around that glute med, tfl area, around hip), pain also radiated down to toes, injection site pain, some neck pain. Patient was self-treated with ice packs, compression, elevation & Biofreeze (topical menthol pain reliever) PRN as a therapeutic measure for all the events. The clinical outcome of the events was reported as recovering.  No follow-up attempts are needed. No further information is expected.